Talon Therapeutics to Host a Conference Call to Report Third Quarter 2011 Financial Results and Business Update on November 15, 2011

SAN MATEO, Calif., Nov. 11, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Tuesday, November 15, 2011 at 9:00AM PT, to include a discussion of financial results and highlights of the third quarter and a business update.

Conference call details:

An archived version of the webcast will also be available via the company's website following the call.

About Talon Therapeutics, Inc.

Talon Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. Talon is developing its lead product candidate, Marqibo, primarily for the treatment of acute lymphoblastic leukemia and lymphomas. The Company has additional pipeline opportunities some of which, like Marqibo, are designed to improve delivery and enhance the therapeutic benefits of well characterized, proven chemotherapies and enable high potency dosing without increased toxicity. Additional information on Talon Therapeutics can be found at www.talontx.com

The Talon Therapeutics, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3290

CONTACT: Talon Therapeutics, Inc.

         Investor & Media Contacts:

         Investor Relations Team

         (650) 588-6641

         investor.relations@talontx.com

News Provided by Acquire Media

Close window | Back to top

• delicious
• Digg
• Facebook
• LinkedIn
• Mixx
• Twitter
• Yahoo! Buzz